Studies Show Success with Bio-Sponge in Treating Horse Diarrhea

Newsdate: Thu, 14 Feb 2013 - 09:46 am

Diarrhea in adult horses and foals is a significant source of morbidity and mortality. The results of a retrospective study conducted in the late 1990’s indicated that more than 25% of horses admitted to a teaching hospital with acute diarrhea did not survive. Of these horses, those treated with antimicrobial drugs, a contributing factor to bacterial overgrowth, had the highest risk of not surviving. 

Fighting deadly diarrhea in horses and foals

Fighting deadly diarrhea in horses and foals

Due to its ability to bind and neutralize clostridial toxins, Bio-Sponge may be particularly useful in horses with colitis and diarrhea caused by clostridial organisms.

Currently, Salmonella organisms are the most frequently cultured pathogenic bacteria in adult horses with diarrhea. Salmonella organisms also have been implicated in post-surgical diarrhea and neonatal septicemia, which is significant because septicemia remains one of the leading causes of illness and death in young foals. In addition, Salmonella are increasingly problematic in the hospital setting with fatality rates as high as 38%. 

Clostridium difficile has also been isolated from and associated with diarrhea in adult horses.

Foal heat diarrhea, which develops in foals 9 to 14 days old, is considered to be a manifestation of normal changes in the microbial ecology of the intestinal tract. However, neonatal diarrhea develops at an earlier age and is often due to gram-negative bacteria, including Salmonella, and gram positive Clostridium species.

Smectite, a naturally occurring organomineral, has shown promise as a protectant against the overgrowth of pathogenic bacteria by reducing the harmful effects of bacterial toxins.

Bio-Sponge™, the commercially available Di-Tri-Octahedral smectite product from Platinum Performance Inc., bound 99% of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxins in one in vitro study and effectively neutralized Clostridium toxins in another study. 

Bio-Sponge™ is suggested to work because it has an ionic charge that allows it to bind to various toxins, creates an environment that is not favorable to the growth of clostridial bacteria, or directly prevents the absorption of toxins by coating the intestinal wall. Due to its ability to bind and neutralize clostridial toxins, Bio-Sponge™ may be particularly useful in horses with colitis and diarrhea caused by clostridial organisms.

Promising results using Bio-Sponge™:

  • Recommended for use when your horse has an intestinal disturbance
  • Comprised of a natural clay, Di-Tri-Octahedral Smectite
  • A negatively charged intestinal adsorbant designed to help support healthy intestinal function
  • Widely used to support healthy gastrointestinal function in foals

Recent studies in adult horses indicate that Bio-Sponge™ may be beneficial in horses after colic surgery and in adult horses with antibiotic-induced colitis. For example, researchers at the University of California, Davis reported a significant decrease in the incidence of diarrhea after colic surgery in horses administered Bio-Sponge™ when compared with horses receiving a placebo.

Whereas only 10% of horses administered Bio-Sponge™ developed diarrhea, 43% of the placebo-treated horses developed diarrhea. In addition, total WBC and neutrophil counts remained significantly higher 24 and 72 hours after surgery in the horses administered Bio-Sponge™ when compared to the placebo-treated horses.

Bio-Sponge™ may also be beneficial in the management of horses with colitis, as the results of a recent pilot study indicated that Bio-Sponge™ helped maintain normal gastrointestinal function in horses with antibiotic-induced colitis.

Bio-Sponge™, an intestinal protectant composed of DTO smectite, may help create an intestinal environment that protects against the harmful effects of microbial overgrowth and toxin production. Additionally, Bio-Sponge™ may be beneficial in horses with endotoxemia, post-operative diarrhea, and after toxin ingestion.

Information from article by Tara Hembrooke, Ph.D., M.S., and Sina Wallace, Ph.D., University of California, Davis

About the Author

Flossie Sellers

Author picture

As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.

She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.

Staying up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere.